BioUtah News
-
PolarityTE Reports Second Quarter 2022 Financial Results and Provides Business Update
PolarityTE provided a business update and reported financial results for the quarterly period ended June 30, 2022.
-
Co-Diagnostics, Inc. Reports Second Quarter 2022 Financial Results
Second quarter results impacted by volume declines; Further progress on the development of the Co-Dx PCR Home platform
-
Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia
The U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation for DSP-5336.
-
New Embolic Device Demonstrates Superior Vessel Filling in Tumor Models
Fluidx Medical’s GPX Embolic Material Yields Promising Results for Oncology Uses
-
Merit Medical Launches SafeGuard Focus Cool™ Compression Device
Modern design advances patient care by combining hemostasis with innovative cooling capability
-
Data Results Published in American Journal of Managed Care demonstrate adoption and clinical utility of KidneyIntelXTM with Primary Care Physicians
98% of 401 Primary Care Physicians confirmed KidneyIntelX has value as a risk decision tool in their adult…
-
Soft Cell Labs announces new Urinary Tract Infection Test
Soft Cell Labs announces new Urinary Tract Infection Test
-
ELITechGroup and InfanDx AG to Collaborate on the Development and Manufacturing of HypoxE® Neonatal Care Test for Clinical Laboratories
ELITechGroup to provide contract development and manufacturing services for HypoxE® IVD Tests designed for Selectra Pro family of…
-
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
bioMérieux receives FDA Clearance for NEPHROCHECK® test on VIDAS®
-
3M Announces Plans to Create Long Term Value Through Spin-Off of Health Care Business
New 3M will remain a leading global material science innovator serving diverse end markets, with science and technology,…
-
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
Tillis and Leahy Introduce Bipartisan Legislation to Improve Patent Quality
-
UTMD Reports Financial Performance for Second Calendar Quarter and First Half 2022
UTMD achieved second calendar quarter (2Q) and first half (1H) 2022 financial results better than those anticipated in…
Call to Action
Post Category
- BioUtah COVID-19 Analysis
- BioUtah News
- Business Tools & Resources
- Call to Action
- chair
- COVID-19 Legislation
- COVID-19 Updates
- Economic Developments
- Events
- Events
- Feature
- Featured Members
- Federal News
- Funding
- Funding
- Guests Posts
- HHS/FDA & Other Regulatory
- HR
- Industry News
- Life Sciences Events
- Life Sciences Industry News
- Newsletters
- Non-chair
- Policy News
- Press Releases
- State News
- Utah's Life Sciences Companies
- Workplace Safety
Latest Posts
- Lumea Named Best New Biopsy Technology Solution in 2026 MedTech Breakthrough Awards
- Co-Diagnostics Develops Ebola Assay Strategy Following Recent Global Outbreak Alert
- BlueWind Medical Secures $47.8 Million Financing to Accelerate Commercialization of Revi® System
- PhotoPharmics Announces Last Patient Last Visit in Pivotal, Phase 3, Light for PD Clinical Trial; Company to Present Topline Data at World Parkinson Congress
- AFTER SUCCESSFUL FDA MEETING, CLENE FILING ACCELERATED APPROVAL NDA FOR ALS
